PALM BEACH, Fla. – The first day of the National Association of Chain Drug Stores Annual Meeting got off to a fast start at a breakfast on GLP-1s sponsored by retailmediaIQ, publisher of Chain Drug Review and MMR. Building on a webinar devoted to the same topic earlier this year, the session addressed the latest developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors. Moderated by Parag Shah, co-founder, partner and chief growth officer at Think Blue, the panelists included Jim Kirby, chief commercial officer at Kroger Health, Betty Pio, a partner and strategic advisor to pharma and biotech at Kearney, and Sarah Squires, director of Retail Insights Drug Channel at NielsenIQ.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Related
NACDS Foundation to host 28th Annual Dinner with Jim Gaffigan at Total Store Expo
Gaffigan, an eight-time Grammy-nominated comedian and three-time Emmy winner, is known for his observational humor and global touring success.
Karl Rove to return as speaker for NACDS-PAC Breakfast at 2026 NACDS Annual Meeting
Renowned political strategist to share insights on the evolving U.S. political landscape.
NACDS Annual Meeting: Board of Directors dinner to honor NACDS President and CEO Steve Anderson
The tribute marks Anderson’s 20 years leading NACDS, highlighting his role in refining strategy, strengthening finances, and boosting influence on healthcare issues.
Powerful perspectives take the stage at 2026 NACDS Annual Meeting
The meeting will feature perspectives linking leadership, innovation, and history during a pivotal time for the country and pharmacy industry.
Latest
Dial rolls out new scents just in time for spring
These everyday essentials are designed to keep skin feeling clean, fresh, and hydrated through it all.
Albertsons Q4 underscores pharmacy pressure
Albertsons’ Q4 results showed continued pressure on its pharmacy, with a $773.8 million opioid-related charge causing a net loss and highlighting reimbursement and pricing issues.
Prescription demand propels growth at Kroger
Strong year-over-year sales growth that was driven by core pharmacy prescription growth and sale of GLP-1 drugs.
Amazon Pharmacy: ‘Clinically forward, convenient’
The business fills gaps in pharmacy deserts through 24/7 access to pharmacists, automatic refills and PillPack.